A flurry of developments in late January 2025 has caused quite a buzz in the AI world. On January 20, DeepSeek released a new open-source AI model called R1 and an accompanying research paper....more
Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies. These challenges often center on intellectual property (IP) risks, licensing...more
1/15/2025
/ Acquisitions ,
Artificial Intelligence ,
Documentation ,
Due Diligence ,
Innovation ,
Intellectual Property Protection ,
IP License ,
Life Sciences ,
Mergers ,
Patents ,
Pharmaceutical Industry ,
Risk Management ,
Startups
AI is poised to revolutionize drug discovery, but uncertainty in developing protectable IP in this emerging field creates a host of potential risks for companies innovating in this space. Further complicating things: not all...more